Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because ofits rarity, limited data are available on potential prognostic parameters. While severalstudies support that carcinomatous components predict outcomes, others do not. In thisstudy, we evaluated the clinical and histopathologic features of 196 uterinecarcinosarcomas to identify potential prognostic factors. Patients’ages ranged from 34to 95 yr (median, 68 yr). Seventy-three (38%) patients experienced tumor recurrenceduring follow-up. Tumors≥5 cm, outer half myometrial invasion, lymphovascularinvasion, lymph node metastasis, advanced stage (International Federation ofGynecology and Obstetrics stages III–IV), sarcomatous component on recurrence,sarcoma ...
Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
tumours) are highly aggressive and have traditionally been regarded as a subtype of uterine sarcoma....
Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because ofits rarity, limited data a...
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
BACKGROUND: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
Aims: To search for favorable prognostic factors in CS on the basis of clinical, morphological and i...
Objectives: The aim of our study was to evaluate the clinicopathological features and prognostic fac...
WOS: 000348831000015PubMed ID: 25611900Objective: We aimed to determine the clinicopathologic featur...
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
Uterine carcinosarcomas are rare and extremely aggressive undifferentiated carcinomas which include ...
Background It is unclear whether uterine carcinosarcoma (UCS) is more aggressive than endometrial se...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
tumours) are highly aggressive and have traditionally been regarded as a subtype of uterine sarcoma....
Uterine carcinosarcomas are rare aggressive biphasic neoplasms. Because ofits rarity, limited data a...
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
BACKGROUND: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
Aims: To search for favorable prognostic factors in CS on the basis of clinical, morphological and i...
Objectives: The aim of our study was to evaluate the clinicopathological features and prognostic fac...
WOS: 000348831000015PubMed ID: 25611900Objective: We aimed to determine the clinicopathologic featur...
Background: Prognostic factors and the standard treatment approach for gynaecological carcinosarcoma...
Uterine carcinosarcomas are rare and extremely aggressive undifferentiated carcinomas which include ...
Background It is unclear whether uterine carcinosarcoma (UCS) is more aggressive than endometrial se...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
Purpose The purpose of this study is to evaluate the clinicopathological characteristics, treatment,...
Uterine carcinosarcomas (UCS) are rare tumors. Consensus regarding therapeutic management in non-met...
Aim: The clinicopathologic characteristics, recurrence patterns, and survival of patients with grade...
The purpose of this study is to evaluate the clinicopathological characteristics, treatment, and pro...
tumours) are highly aggressive and have traditionally been regarded as a subtype of uterine sarcoma....